EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS)

Xue Zhao, Yu Cheng, Shen He, Fan Mou, Wei Li iD, Shunying Yu

Alpha Psychiatry · 2026-04-21 · 27 (2)

DOI: 10.31083/ap44501 ↗

At a glance

Journal article in Alpha Psychiatry, published online on 2026-04-21. Written by Xue Zhao and 5 co-authors. Institution: Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 200030 Shanghai, China. Cited 2 times so far (Crossref); 44 references. The full text is freely available (open access, CC BY 4.0). Funded by: Shanghai Jiao Tong University Medical–Industrial Interdisciplinary Fund, 2021 Annual Project of Shanghai Mental Health Center (SMHC) Clinical Research Center, Shanghai Municipal Health Commission Youth Fund Project.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

This pharmacovigilance study aimed to characterize the spectrum of seizure-related adverse events (AEs) associated with eight commonly used atypical antipsychotics (AAPs)—clozapine, quetiapine, olanzapine, aripiprazole, ziprasidone, risperidone, lurasidone, and paliperidone—based on the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database, and to explore potential receptor mechanisms underlying AAP-related seizures.

Methods

Disproportionality analysis was performed using FAERS data from the first quarter of 2004 to the second quarter of 2025. Signal values were assessed using the Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Multi-item Gamma Poisson Shrinker (MGPS) algorithms. Spearman correlation analysis was performed to examine associations between ROR values and receptor binding affinity (Ki) data for D1, D2, D3, 5-HT1A, 5-HT2A, 5-HT2C receptors and 5-HT1A/D2, 5-HT2A/D2, and 5-HT2C/D2 receptor ratios.

Results

The final analysis included 9057 reports of AAPs–seizures pairs (N ≥3), and 8540 cases demonstrating significant seizures-related signals detected by ROR analysis at the preferred term (PT) level. The eight AAPs demonstrated distinct seizures AE profiles, with quetiapine associated with the broadest spectrum (15 PTs). At the High-Level Group Term (HLGT) level, ziprasidone showing the strongest association (ROR025 = 3.21), followed by quetiapine (ROR025 = 2.62), clozapine (ROR025 = 2.58), olanzapine (ROR025 = 2.53) and aripiprazole (ROR025 = 2.05). Risperidone, paliperidone, and lurasidone exhibited comparatively lower signals. Spearman correlation analysis revealed a significant negative correlation between the 5-HT1A/D2 receptor affinity ratio and ROR values (rs = –0.79, p = 0.036).

Conclusions

This large-scale real-world analysis suggests that clozapine, quetiapine, olanzapine, aripiprazole, and particularly ziprasidone are associated with higher reporting signals for seizures compared with risperidone, paliperidone, and lurasidone. The inverse correlation with the 5-HT1A/D2 ratio suggests a potential pharmacodynamic mechanism. Clinicians should consider these differential risks, especially when prescribing for patients with predisposing factors, and maintain vigilance for specific seizures types. These findings warrant further validation through prospective studies and clinical causality assessments.

Subjects

Author keywords

FAERSantipsychotic agentsdisproportionality analysispharmacovigilanceseizures

Authors and institutions

  • Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, 200030 Shanghai, China.

ORCID profiles: Wei Li

Funding

  • Shanghai Jiao Tong University Medical–Industrial Interdisciplinary Fund
  • 2021 Annual Project of Shanghai Mental Health Center (SMHC) Clinical Research Center
  • Shanghai Municipal Health Commission Youth Fund Project
  • Shanghai Mental Health Center Foundation
  • Traditional Chinese Medicine Research Project of Shanghai Municipal Health Commission
  • Shanghai Institute of Traditional Chinese Medicine for Mental Health

Cite

APA

Zhao, X., Cheng, Y., He, S., Mou, F., Li, W., & Yu, S. (2026). Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS). Alpha Psychiatry, 27(2). https://doi.org/10.31083/ap44501

Vancouver

Zhao X, Cheng Y, He S, Mou F, Li W, Yu S. Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS). Alpha Psychiatry. 2026;27(2). doi:10.31083/ap44501

BibTeX
@article{Zhao2026,
  author = {Zhao, Xue and Cheng, Yu and He, Shen and Mou, Fan and Li, Wei and Yu, Shunying},
  title = {Seizures Risk Related to Atypical Antipsychotics: A Disproportionality Analysis Based on the FDA Adverse Event Reporting System (FAERS)},
  journal = {Alpha Psychiatry},
  year = {2026},
  volume = {27},
  number = {2},
  doi = {10.31083/ap44501}
}
Start for free →